Prm158 - Predictive Biomarkers of Treatment Success in Advanced Non–small Cell Lung Cancer Patients Using Multivariate Causal Inference.

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2278
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Predictive Role of Plasmatic Biomarkers in Advanced Non-Small Cell Lung Cancer Treated by Nivolumab

OncoImmunology
OncologyAllergyImmunology
2018English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Targeting Angiogenesis in Advanced Non-Small-Cell Lung Cancer: Are Biomarkers Needed?

Current Respiratory Care Reports
2013English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Circadian Function in Patients With Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

Redefining Treatment Paradigms in First-Line Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Health State Utility Values in Advanced Non-Small Cell Lung Cancer Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy